Reporting the counterparty's growth as its own: management explains the company's coming year by narrating what its cust
The model's full reasoning — Q1 2024 call → NOWe need to determine if management explains where the company's business is going by narrating what its counterparties are themselves doing and scaling. The question asks: does a substantial part of management's forward account consist of reporting on the growth, expansion, ramp, adoption, or program build-out of specific customers, partners, licensees, distributors, payers, operators, or programs the company ALREADY SUPPLIES OR SERVES, such that the company's own coming volume is presented as a consequence of those parties' own trajectories rather than of the company's selling effort? We need to look at the transcript. Management (Jeff Liaw and Leah Stearns) discuss various aspects. They talk about insurance business, total loss frequency, vehicle prices, repair costs, etc. They talk about their own actions: investments, technology, automation, expanding buyer base, etc. They mention growth in Blue Car, dealer sales, specialty equipment, Purple Wave investment, etc. But the key is: do they narrate what their counterparties (e.g., insurance companies, dealers, fleet operators) are themselves doing and scaling? They mention that insurance volumes are increasing, but they attribute that to total loss frequency recovery, which is driven by macro factors like vehicle prices vs repair costs. They don't describe specific insurance companies' own ramps or programs. They talk about their own efforts to serve them better. They mention "we continue to observe a rebound in total loss frequency" - that's a market condition, not a counterparty's own trajectory. They talk about "our insurance customers" but not about what those customers are building or scaling. They mention "we continue to grow our Blue Car business" - that's their own growth. They mention "we increased our dealer sales volume" - again their own. They mention Purple Wave as an investment, but that's a new acquisition, not a counterparty they already serve. They talk about "our global buyer base" - that's their own.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| FNV | Franco-Nevada Corporation | Q3 2016 | 2016-11-08 | B+ |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
OOMA · Q3 2022 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future volume as a consequence of those parties' trajectories.
MBLY · Q2 2023 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's volume as a consequence of those parties' trajectories.
ILMN · Q1 2018 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future as a consequence of those parties' trajectories.